Mirati Therapeutics, Inc. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mirati Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Mirati Therapeutics, Inc. for January 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 30 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | A | 5.40 | 50,000 | 270,000 | 50,000 | |
Jan 30 2017 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 5.40 | 110,000 | 594,000 | 110,000 | |
Jan 30 2017 | MYG | Mirati Therapeutic ... | CHEN ISAN | Sr. VP, Chief Medic ... | Option Exercise | A | 5.40 | 50,000 | 270,000 | 50,000 | |
Jan 30 2017 | MYG | Mirati Therapeutic ... | LEMASTERS CHRISTOPHER C. | EVP, Chief Business ... | Option Exercise | A | 5.40 | 11,250 | 60,750 | 11,250 | |
Jan 30 2017 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | A | 5.40 | 50,000 | 270,000 | 50,000 | |
Jan 30 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.45 | 28,839 | 157,173 | 2,880,702 | 2.9 M to 2.9 M (+1.01 %) |
Jan 30 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.44 | 19,330 | 105,155 | 2,851,863 | 2.8 M to 2.9 M (+0.68 %) |
Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.42 | 30,600 | 165,852 | 2,832,533 | 2.8 M to 2.8 M (+1.09 %) |
Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.32 | 27,682 | 147,268 | 2,801,933 | 2.8 M to 2.8 M (+1.00 %) |
Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.27 | 19,251 | 101,453 | 2,774,251 | 2.8 M to 2.8 M (+0.70 %) |
Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.42 | 23,873 | 129,392 | 2,755,000 | 2.7 M to 2.8 M (+0.87 %) |
Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.48 | 21,085 | 115,546 | 2,731,127 | 2.7 M to 2.7 M (+0.78 %) |
Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 16,200 | 89,100 | 2,710,042 | 2.7 M to 2.7 M (+0.60 %) |
Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 17,800 | 97,900 | 2,693,842 | 2.7 M to 2.7 M (+0.67 %) |
Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.49 | 52,311 | 287,187 | 2,676,042 | 2.6 M to 2.7 M (+1.99 %) |
Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 49,776 | 273,768 | 2,623,731 | 2.6 M to 2.6 M (+1.93 %) |
Jan 10 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | P | 0.00 | 4,865,430 | 4,865 | 4,865,430 | |
Jan 10 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.60 | 581,870 | 3,258,472 | 2,573,955 | 2 M to 2.6 M (+29.21 %) |
Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | P | 0.00 | 51,047 | 51 | 51,047 | |
Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | P | 0.00 | 2,341,786 | 2,342 | 2,341,786 | |
Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 5.60 | 6,104 | 34,182 | 435,444 | 429.3 K to 435.4 K (+1.42 %) |
Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 5.60 | 280,059 | 1,568,330 | 1,037,994 | 757.9 K to 1 M (+36.95 %) |